The Role of Antibiotics in Full Thickness Skin Graft Survival for Facial Reconstructive Surgery
Sponsor: University of Michigan
A PHASE4 clinical study on Facial Defect, this trial is actively recruiting participants. The trial is conducted by University of Michigan and has accumulated 13 data snapshots since 2013. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
13 versions recorded-
Apr 2025 — Present [monthly]
Recruiting PHASE4
-
Sep 2024 — Apr 2025 [monthly]
Recruiting PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Recruiting PHASE4
-
May 2024 — Jul 2024 [monthly]
Recruiting PHASE4
-
Jun 2023 — May 2024 [monthly]
Recruiting PHASE4
▶ Show 8 earlier versions
-
Jul 2022 — Jun 2023 [monthly]
Recruiting PHASE4
-
Jun 2021 — Jul 2022 [monthly]
Recruiting PHASE4
-
Jan 2021 — Jun 2021 [monthly]
Recruiting PHASE4
-
Jun 2020 — Jan 2021 [monthly]
Recruiting PHASE4
-
Jun 2019 — Jun 2020 [monthly]
Recruiting PHASE4
-
Jun 2018 — Jun 2019 [monthly]
Recruiting PHASE4
-
Feb 2017 — Jun 2018 [monthly]
Recruiting PHASE4
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE4
First recorded
Jul 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Michigan
For direct contact, visit the study record on ClinicalTrials.gov .